Immunex
Executive Summary
Licensing agreement with Hoechst subsidiary Behringwerke is signed for the manufacture and marketing of soluble receptor products in Japan, company said March 14. Immunex will receive an up-front payment of $3 mil. and product royalties, as well as two additional payments based on performance milestones. The biotech firm says that the three installments will exceed the $7.3 mil. paid to acquire the rights for the products in 1989.